News Agency
Men's Weekly

Aucta announced FDA approval of a generic version of Trileptal®(oxcarbazepine) oral suspension

  • Written by PR Newswire

PISCATAWAY, N.J., Dec. 5, 2022 /PRNewswire/ -- Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals"), announced today the U.S. approval of a generic version of Trileptal® (oxcarbazepine) oral suspension, 300 mg/5 mL[1]. Aucta will commercialize this product in early 2023.

Oxcarbazepine oral suspension had annual sales in the U.S. exceeding $74...

Read more: Aucta announced FDA approval of a generic version of Trileptal®(oxcarbazepine) oral suspension

How Signage Shapes Business Visibility And Customer Perception

In today’s competitive commercial environment, signage is far more than just a display element—it acts as a silent communicator between a business and its audience. Whether positioned outdoors or within a retail or corporate space, it provides immediate information about what... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion